ODDB.org: Open Drug Database

Horizon Therapeutics Switzerland GmbH - Uplizna 100 mg/10ml, Konzentrat zur Herstellung einer Infusionslösung

Swissmedic Registration	69322	Sequence	01
Product name	Uplizna 100 mg/10ml	Description	Konzentrat zur Herstellung einer Infusionslösung
ATC-Classification	L04AA47	ATC-Description	Inebilizumab
Introduction of Sequence	04.03.2024

Composition

inebilizumabum 100 mg, histidinum, histidini hydrochloridum monohydricum, natrii chloridum, trehalosum dihydricum, polysorbatum 80, aqua ad iniectabile, ad solutionem pro 10 ml corresp., natrium 16.1 mg.

Packungsbestandteile

Galenic Form

Concentrate for infusion

Excipiens

Active Agent	Dose
Inebilizumabum	100mg / 10ml

Inactive agents
Histidin Hydrochloride Monohydrate
Histidine
Sodium Chloride
Polysorbatum 80
Trehalosum Dihydricum

Package number	Package Size	EFP	CP	Category	SL	Out of trade (MedRef)
001	3	PR	PR	A		No

2024	©ywesee GmbH